These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 395680

  • 21. [Action of beta blockaders in hypertension caused by isthmic aortic coarctation: a new proof in favor of renin-angiotensin system].
    Lardoux H, Battino A, Maurice P, Corvol P, Milliez P, Girardet JP.
    Nouv Presse Med; 1978 Jan 07; 7(1):45-6. PubMed ID: 662602
    [No Abstract] [Full Text] [Related]

  • 22. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
    Baker KM, Johns DW, Vaughan ED, Ayers CR, Carey RM.
    Clin Exp Hypertens (1978); 1980 Jan 07; 2(6):947-54. PubMed ID: 7004807
    [No Abstract] [Full Text] [Related]

  • 23. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct 07; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 24. Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma.
    Röckel A, Heidland A, Appel E, Palm D.
    N Engl J Med; 1977 Jan 06; 296(1):50-1. PubMed ID: 830274
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical and experimental studies on the angiotensin inhibitor 1-sar-8-ile-angiotensin II (P 165)].
    Werner U, Waelsch I, Bock KD.
    Verh Dtsch Ges Inn Med; 1976 Jan 06; 82 Pt 2():1310-3. PubMed ID: 1029986
    [No Abstract] [Full Text] [Related]

  • 26. [Postoperative hypertension in coarctation of the aorta associated with different plasma renin activities and catecholamine responses in two cases].
    Sudo K, Nakagomi E, Hamada Y, Morita H, Mizunuma H, Unno T, Hayashi N, Ikeda K, Mizuno A.
    Kyobu Geka; 1988 Nov 06; 41(12):988-93. PubMed ID: 3062216
    [No Abstract] [Full Text] [Related]

  • 27. [Significance of the renin-angiotensin system in the hypertension of aortic coarctation].
    Werning C, Schönbeck M, Weidmann P, Baumann K, Gysling E, Wirz P, Siegenthaler W.
    Helv Med Acta Suppl; 1969 Nov 06; 49():188. PubMed ID: 4315795
    [No Abstract] [Full Text] [Related]

  • 28. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP, Ledingham JG.
    Clin Sci Mol Med; 1978 Mar 06; 54(3):305-12. PubMed ID: 630806
    [No Abstract] [Full Text] [Related]

  • 29. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD, Kirschenbaum MA, Rosenblatt SG, Gibney R.
    Ann Intern Med; 1978 Jan 06; 88(1):23-7. PubMed ID: 619754
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA, Dawes PM.
    Aust N Z J Med; 1976 Aug 06; 6(3 Suppl):53-4. PubMed ID: 1071404
    [Abstract] [Full Text] [Related]

  • 31. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977 Aug 06; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 32. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK, Williams GH, Adams DF, Moore T, Brown C, Borucki LJ, Leung F, Bavli S, Solomon HS, Passan D, Dluhy R.
    Medicine (Baltimore); 1979 Mar 06; 58(2):115-27. PubMed ID: 431398
    [No Abstract] [Full Text] [Related]

  • 33. The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
    Zawada ET, Maxwell MH, Marks LS, Lee DB, Kaufman JJ.
    J Urol; 1980 Feb 06; 123(2):148-52. PubMed ID: 6986475
    [Abstract] [Full Text] [Related]

  • 34. Angiotensin blockade in hypertension.
    Streeten DH, Anderson GH.
    Ann Intern Med; 1977 Mar 06; 86(3):353-4. PubMed ID: 842997
    [No Abstract] [Full Text] [Related]

  • 35. Letter: Hypotension during angiotensin blockade with saralasin.
    Pettinger WA, Keeton K.
    Lancet; 1975 Jun 21; 1(7921):1387-8. PubMed ID: 48980
    [No Abstract] [Full Text] [Related]

  • 36. Angiotensin blockade: its clinical significance.
    Streeten DH, Anderson GH, Dalakos TH.
    Am J Med; 1976 May 31; 60(6):817-24. PubMed ID: 1020761
    [Abstract] [Full Text] [Related]

  • 37. [Residual arterial hypertension in coartectomized patients. Pathogenetic role of the renin-angiotensin-aldosterone system and of residual isthmic stenosis].
    Carazo Carazo M, Alonso Pulpón L, González M, de Teresa E, Puente Rodero B, Puente A, Ortigosa J, de Artaza M.
    Rev Esp Cardiol; 1983 May 31; 36(3):193-7. PubMed ID: 6356247
    [No Abstract] [Full Text] [Related]

  • 38. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP, Rosenthal J, Wagner H, Franz HE.
    Proc Eur Dial Transplant Assoc; 1978 May 31; 15():412-7. PubMed ID: 740674
    [Abstract] [Full Text] [Related]

  • 39. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T, Nakamaru M, Higaki J, Hata T, Kumagai A, Kumahara Y.
    Med J Osaka Univ; 1983 Sep 31; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract] [Full Text] [Related]

  • 40. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A, Shaldon S, Barjon P, Mion C.
    Clin Nephrol; 1978 Feb 31; 9(2):63-7. PubMed ID: 639368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.